Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.

Documenti analoghi

• In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
  di: Gao, Q, et al.
  Pubblicazione: (1992)
• Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus.
  di: Bruzzese, V L, et al.
  Pubblicazione: (1995)
• The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.
  di: Gao, Q, et al.
  Pubblicazione: (1993)
• Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
  di: Gu, Z, et al.
  Pubblicazione: (1992)
• Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
  di: Malley, S D, et al.
  Pubblicazione: (1994)